Your browser doesn't support javascript.
loading
Interleukin-6 receptor antagonists in immunopsychiatry: Can they lead to increased interleukin-6 in the central nervous system (CNS) and worsening psychiatric symptoms?
Mac Giollabhui, N; Foster, S; Lowry, C A; Mischoulon, D; Raison, C L; Nyer, M.
Affiliation
  • Mac Giollabhui N; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Department of Psychology, Temple University, Philadelphia, PA, USA. Electronic address: nmacgiollabhui@mgh.harvard.edu.
  • Foster S; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
  • Lowry CA; Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA.
  • Mischoulon D; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
  • Raison CL; School of Human Ecology, University of Wisconsin, Madison, Madison, WI, USA; Usona Institute, Fitchberg, WI, USA.
  • Nyer M; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Brain Behav Immun ; 103: 202-204, 2022 07.
Article in En | MEDLINE | ID: mdl-35452794
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Mental Disorders Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Brain Behav Immun Journal subject: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Mental Disorders Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Brain Behav Immun Journal subject: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Year: 2022 Type: Article